News

Portfolio Companies
in the News

ShiraTronics Completes Australian Pilot Study Enrollment; Prepares for Pivotal Clinical Study

February 6, 2024

Read More ›

Synergy Spine Solutions Announces $30M Financing

January 31, 2024

Read More ›

Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure

November 2, 2023

Read More ›

Contego Medical Announces One-Year Outcomes From The Performance II Carotid Stent Trial

November 1, 2023

Read More ›

Trinity Capital Inc. Provides $25 Million Growth Capital to Neuros Medical, Inc.

October 31, 2023

Read More ›

Contego Medical Announces Start of Enrollment in Performance III Direct Transcarotid Access Stenting Trial

October 6, 2023

Read More ›

Thryv Therapeutics announces FDA clearance for Phase 1 Study of THRV-1257 in Anaplastic Thyroid Cancer and acceptance of Late-Breaking Poster Presentation at American Thyroid Association Meeting.

August 15, 2023

Read More ›

Impulse Dynamics Announces First Implant for CCM-D™ Clinical Trial

May 18, 2023

Read More ›

Miach Orthopaedics Launches BEAR® Implant Registry Study

May 2, 2023

Read More ›

© 2024 Amzak Health | Privacy Policy | Luxury Marketing Mediaboom

category

medtech

status

Current

headquarters

Plymouth, Minnesota

website

Visit Website ›

HistoSonics

HistoSonics has developed a system to destroy tumors completely non-invasively. Treatment is achieved using histotripsy, a novel form of energy that is safe, extremely precise, and able to be personalized for each patient. The initial indication is for treatment of liver tumors and the system is being studied in several other types of tumors.